Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Prostate/GU Posters

  • You have access
    Pilot evaluation of 1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma
    Bital Savir-Baruch, David Schuster, Nachwa Jarkas, Viraj Master, Peter Nieh, Raghuveer Halkar, Jonathon Nye, Melinda Lewis, David Roberts and Mark Goodman
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1266;
  • You have access
    Impact of FDG PET/CT on the decision making of initial treatment of urethral cancer
    Yamin Dou, Edward Pinkus and Lyubov Girshovich
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1273;
  • You have access
    Assessment of nuclear grading of clear cell renal cell carcinoma using F-18 FDG PET/CT: A preliminary study
    Kentaro Takanami, Tomomichi Hiraide, Hiroshi Fukuda and Shoki Takahashi
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1270;
  • You have access
    Inguinal lymph nodes in patients undergoing clinical C-11 Acetate PET/CT for prostate cancer
    Muhammad Chaudhry, Corina Voicu, Elizabeth Prusha, Lawrence Shombert and Richard Wahl
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1265;
  • You have access
    Tumor volume in prostate cancer assessed by [11C]Choline PET/CT: Validation with surgical specimen
    Ralph Bundschuh, Christina Wendl, Gregor Weirich, Uwe Treiber, Hans Geinitz, Anca Grosu, Markus Schwaiger, Sibylle Ziegler and Bernd Joachim Krause
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1268;
  • You have access
    11C-Choline PET/CT image-guided tomotherapy treatment of lymph nodal relapse in prostate cancer patients
    Maria Picchio, Filippo Alongi, Giampiero Giovacchini, Genoveffa Berardi, Elena Busnardo, Cinzia Crivellaro, Luigi Gianolli, Nadia Di Muzio and Cristina Messa
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1274;
  • You have access
    Comparison of bone scintigraphy with Tc-99m-DPD and PET/CT with C-11-choline for the detection of bone metastases in patients with prostate cancer
    Philip Aschoff, Andre Rieger, Matthias Werner, David Schilling, Susanne Eschmann and Christina Pfannenberg
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1275;
  • You have access
    Evaluation of multikinase inhibitor treatment response for renal cell carcinoma by FDG-PET/contrast enhanced CT
    Ryogo Minamimoto, Noboru Nakaigawa, Ukihide Tateishi, Kazuya Shizukuishi, Kubota Yoshinobu and Tomio Inoue
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1272;
  • You have access
    Monitoring treatment response in high risk prostate cancer patients using C-11 choline PET/CT
    Daniel Fried, Sudha Garg, Anita Thomas, Martha Wasserman, Aruna Korde, William Kearns, John Bourland and Pradeep Garg
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1263;
  • You have access
    Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at conventional imaging methods
    Chiara Fuccio, Paolo Castellucci, Ivan Santi, Paola Caroli, Ilaria Grassi, Egesta Lopci, Monica Celli, Silvia Nicolini, Lorenzo Fantini and Stefano Fanti
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1271;

Pages

  • Next
  • 1
  • 2
SNMMI

© 2025 SNMMI

Powered by HighWire